Atrasentan Hydrochloride K inhibitor 4 (trans) 2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H

2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H

Smiles: [NH3+][Pt-2]1([NH3+])OCC(=O)O1

RO1138452 is a potent and selective antagonist for both human and rat IP receptors and that is possesses analgesic and anti-inflammatory potential

4]triazin-4(1H)-one dihydrochloride trihydrate

Atrasentan Hydrochloride K inhibitor 4 (trans) 2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4HAtrasentan, also known as ABT 627, is a orally available ETA receptor antagonist with potential antineoplastic activity. As a selective antagonist of the endothelin A (ETA) receptor, atrasentan binds selectively to the ETA receptor, which may result in inhibition of endothelin induced angiogenesis and tumor cell proliferation. Product information CAS Number: 195733 43 8 Molecular Weight: 547. 08 Formula: C29H39ClN2O6 Chemical Name: (2R,3R,4S) 4 (2H